Aila Sarkesh

663 total citations · 1 hit paper
20 papers, 361 citations indexed

About

Aila Sarkesh is a scholar working on Oncology, Immunology and Neurology. According to data from OpenAlex, Aila Sarkesh has authored 20 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 6 papers in Immunology and 4 papers in Neurology. Recurrent topics in Aila Sarkesh's work include CAR-T cell therapy research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Immunotherapy and Immune Responses (3 papers). Aila Sarkesh is often cited by papers focused on CAR-T cell therapy research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Immunotherapy and Immune Responses (3 papers). Aila Sarkesh collaborates with scholars based in Iran, Cyprus and Türkiye. Aila Sarkesh's co-authors include Amin Daei Sorkhabi, Leili Aghebati‐Maleki, Ali Aghebati‐Maleki, Leila Mohamed Khosroshahi, Behzad Baradaran, Amirhossein Mardi, Hossein Bannazadeh Baghi, Mehdi Yousefi, Nima Hemmat and Farbod Alinezhad and has published in prestigious journals such as PLoS ONE, Frontiers in Immunology and Gene.

In The Last Decade

Aila Sarkesh

18 papers receiving 353 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies

2023 124 citations Amin Daei Sorkhabi, Leila Mohamed Khosroshahi et al. Frontiers in Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aila Sarkesh Iran	10	162	114	74	49	46	20	361
Amin Daei Sorkhabi Iran	10	161 1.0×	118 1.0×	92 1.2×	49 1.0×	51 1.1×	22	374
Dionne Davis United States	8	172 1.1×	110 1.0×	147 2.0×	38 0.8×	23 0.5×	10	472
Heather M. Sonnemann United States	4	183 1.1×	130 1.1×	81 1.1×	37 0.8×	21 0.5×	7	384
Caitlin Marie Reid United States	4	234 1.4×	174 1.5×	116 1.6×	39 0.8×	16 0.3×	5	479
Paul Baran Germany	8	250 1.5×	270 2.4×	145 2.0×	37 0.8×	41 0.9×	9	568
Omid Kooshkaki Iran	11	185 1.1×	118 1.0×	150 2.0×	14 0.3×	21 0.5×	17	419
Jessica K. Wang United States	7	132 0.8×	159 1.4×	180 2.4×	49 1.0×	24 0.5×	9	451
Annaïse Jauch Switzerland	5	108 0.7×	334 2.9×	138 1.9×	22 0.4×	57 1.2×	9	507
Jeremy D. Rubinstein United States	13	198 1.2×	41 0.4×	119 1.6×	37 0.8×	66 1.4×	39	455
Anat Klein Israel	13	236 1.5×	111 1.0×	187 2.5×	19 0.4×	23 0.5×	18	560

Countries citing papers authored by Aila Sarkesh

Since Specialization

Citations

This map shows the geographic impact of Aila Sarkesh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aila Sarkesh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aila Sarkesh more than expected).

Fields of papers citing papers by Aila Sarkesh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aila Sarkesh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aila Sarkesh. The network helps show where Aila Sarkesh may publish in the future.

Co-authorship network of co-authors of Aila Sarkesh

This figure shows the co-authorship network connecting the top 25 collaborators of Aila Sarkesh. A scholar is included among the top collaborators of Aila Sarkesh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aila Sarkesh. Aila Sarkesh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Safiri, Saeid, Amir Ghaffari Jolfayi, Asra Fazlollahi, et al.. (2024). Alzheimer's disease: a comprehensive review of epidemiology, risk factors, symptoms diagnosis, management, caregiving, advanced treatments and associated challenges. Frontiers in Medicine. 11. 1474043–1474043. 38 indexed citations

Sorkhabi, Amin Daei, et al.. (2024). Viruses and thrombocytopenia. Heliyon. 10(6). e27844–e27844. 9 indexed citations

Sadeghi‐Hokmabadi, Elyar, et al.. (2024). Efficacy and safety of direct oral anticoagulants versus warfarin in the treatment of cerebral venous sinus thrombosis. Acta Neurologica Belgica. 124(5). 1655–1662.

Safiri, Saeid, Amin Daei Sorkhabi, Aila Sarkesh, et al.. (2024). Obesity: Global Epidemiology, Trends, Risk Factors, and Clinical Aspects. 2. e19–e19. 3 indexed citations

Sorkhabi, Amin Daei, Asra Fazlollahi, Aila Sarkesh, et al.. (2023). The safety and efficacy of tislelizumab, alone or in combination with chemotherapy, for the treatment of non-small cell lung cancer: a systematic review of clinical trials. BMC Pulmonary Medicine. 23(1). 495–495. 8 indexed citations

Sorkhabi, Amin Daei, et al.. (2023). A systematic review of the safety and efficacy of monoclonal antibodies for progressive multiple sclerosis. International Immunopharmacology. 120. 110266–110266. 4 indexed citations

Sarkesh, Aila, Amin Daei Sorkhabi, Amirreza Naseri, et al.. (2023). Radiological features of late-onset multiple sclerosis: A systematic review and meta-analysis. Journal of Neuroradiology. 50(6). 571–580. 7 indexed citations

Sorkhabi, Amin Daei, et al.. (2023). Diagnostic value of an increase in central venous pressure during SBT for prediction of weaning failure in mechanically ventilated patients: A cross‐sectional study. Health Science Reports. 6(4). e1204–e1204.

Sarkesh, Aila, Amin Daei Sorkhabi, Forough Parhizkar, et al.. (2023). The immunomodulatory effect of intradermal allogeneic PBMC therapy in patients with recurrent spontaneous abortion. Journal of Reproductive Immunology. 156. 103818–103818. 9 indexed citations

10.

Sarkesh, Aila, et al.. (2023). Current status of skin cancers with a focus on immunology and immunotherapy. Cancer Cell International. 23(1). 174–174. 31 indexed citations

11.

Sorkhabi, Amin Daei, Asra Fazlollahi, Aila Sarkesh, et al.. (2023). Efficacy and safety of veliparib plus chemotherapy for the treatment of lung cancer: A systematic review of clinical trials. PLoS ONE. 18(9). e0291044–e0291044. 2 indexed citations

12.

Sorkhabi, Amin Daei, Leila Mohamed Khosroshahi, Aila Sarkesh, et al.. (2023). The current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies. Frontiers in Immunology. 14. 1113882–1113882. 124 indexed citations breakdown →

13.

Sorkhabi, Amin Daei, et al.. (2023). Advances in immune checkpoint-based immunotherapies for multiple sclerosis: rationale and practice. Cell Communication and Signaling. 21(1). 321–321. 4 indexed citations

14.

Sarkesh, Aila, Amin Daei Sorkhabi, Samaneh Abdolmohammadi‐Vahid, et al.. (2022). Allogeneic lymphocytes immunotherapy in female infertility: Lessons learned and the road ahead. Life Sciences. 299. 120503–120503. 19 indexed citations

15.

Sorkhabi, Amin Daei, Aila Sarkesh, Hossein Saeedi, et al.. (2022). The Basis and Advances in Clinical Application of Cytomegalovirus-Specific Cytotoxic T Cell Immunotherapy for Glioblastoma Multiforme. Frontiers in Oncology. 12. 818447–818447. 14 indexed citations

16.

Yang, Xiaoyu, Yan Wang, Heshu Sulaiman Rahman, et al.. (2022). Expression of proliferation-related genes in BM-MSC-treated ALL cells in hypoxia condition is regulated under the influence of epigenetic factors in-vitro. Medical Oncology. 39(7). 88–88. 1 indexed citations

17.

Shomali, Navid, Behzad Baradaran, Amin Daei Sorkhabi, et al.. (2022). Survivin; a novel therapeutic target that correlates with survival of autoreactive T lymphocytes obtained from patients with ankylosing spondylitis. Gene. 844. 146829–146829. 10 indexed citations

18.

Sorkhabi, Amin Daei, Aila Sarkesh, Ali Fotouhi, Hossein Saeedi, & Leili Aghebati‐Maleki. (2022). Cancer combination therapies by silencing of CTLA‐4, PD‐L1, and TIM3 in osteosarcoma. IUBMB Life. 74(9). 908–917. 16 indexed citations

19.

Sorkhabi, Amin Daei, et al.. (2021). Vitamin supplementation as a potential adjunctive therapeutic approach for COVID-19: biological and clinical plausibility. Journal of Basic and Clinical Physiology and Pharmacology. 33(1). 55–77. 11 indexed citations

20.

Sarkesh, Aila, Amin Daei Sorkhabi, Elham Sheykhsaran, et al.. (2020). Extrapulmonary Clinical Manifestations in COVID-19 Patients. American Journal of Tropical Medicine and Hygiene. 103(5). 1783–1796. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact